Menu
Puma Biotechnology wordmark
Puma Biotechnology announced it will enact 340B contract pharmacy restrictions effective Jan. 1, 2026.

Puma Biotechnology 40th Drugmaker to Enact 340B Contract Pharmacy Restrictions, 2nd to Use Kalderos’ Truzo Platform

Shannon Young, Associate Editor/Senior Writer 340B Report Views
A California biotechnology company on Monday became the 40th drugmaker to announce restrictions on 340B covered entities’ use of contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

AstraZeneca Adds Drug to 340B Contract Pharmacy Restrictions, Sanofi Ends Oklahoma Exemption

Preparing for the 340B Rebate Model

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live